Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03529682
Other study ID # 2017/51-21
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2018
Est. completion date November 2018

Study information

Verified date May 2018
Source Eastern Mediterranean University
Contact UNAL DEGER, MSc
Phone 05428532184
Email unal.deger@emu.edu.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of our study is to reveal the results of circuit training to be applied to the children with Cerebral Palsy (CP) for improving their muscular strength and trunk control and also to determine their effects in terms of activity limitations and participation limits.


Description:

According the power analyzes totally 62 children, as 31 per each group, who were diagnosed with Spastic type CP and accepting participation for the study will be included in this study. For every case, socio demographic data and clinical features will be recorded. In the first session their gross motor function, muscular tonus in lower extremities, isometric strength of lower extremity muscles, functional muscular strength of the trunk and the lower extremities, walking speed and main mobility, functional motor performance will be assessed by a physiotherapist. Also satisfaction of children from the exercises, activity and participation level and quality of life will be evaluated. Then Covariant Focused Randomization Method will be used for having similarity in terms of factors such as; age, gender and motor function levels and also for having a balanced and equal case number of control and intervention group. The control group participants will continue to their own previous physiotherapy approaches (Bobath approach, traditional physiotherapy, etc.). "Circuit exercise training" will be given to the intervention group participants during 10 weeks, 3 times a week and that changes 50-60 minutes. At the end of the 10 weeks, the above evaluation parameters will be repeated


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 62
Est. completion date November 2018
Est. primary completion date August 2018
Accepts healthy volunteers No
Gender All
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria:

- The children who were diagnosed with Spastic type Cerebral Palsy.

- is aged between 6-18,

- is on the I,II and III levels according to Gross Motor Function Classification System

Exclusion Criteria:

- having any surgical operation related to lower extremities for the last 1 year,

- having botulinum toxin injection or intrathecal pump for the last 6 months,

- taking a new medicine or medicine change for the last 1 month,

- visual, hearing and epilepsy problem,

- inability to continuously attend the exercise program,

- mental problem that could not be cooperated.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
exercise
10 minutes warm-up exercises and stretching exercises, 40 minutes consecutive exercises (strengthening exercises for trunk and lower extremities) and 10 minutes cooling down exercises and stretching exercises will be applied.
control group
60 minutes in a day and 3 times in a week traditional physiotherapy program will be applied

Locations

Country Name City State
Cyprus Eastern Mediterranean University Famagusta

Sponsors (1)

Lead Sponsor Collaborator
Eastern Mediterranean University

Country where clinical trial is conducted

Cyprus, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gross Motor Function will be evaluated As for the Gross Motor Function evaluation, the Gross Motor Function Scale (GMFS) will be used and only its D and E sections (standing, walking, running, jumping evaluation parts) will be used. By considering the instructions in to be tested parts in the scale, the case is expected to do the motor functions actively. Without the consideration of the quality of the movement, the case will be observed whether s/he started, was able to continue and completed the movement as well as whether s/he needed any support so that points between 0-3 will be given according to the level. The obtained total score determines the interaction severity of gross motor function Change from baseline GMFS at 10 weeks
Secondary Functional muscular strength of the trunk and the lower extremities will be evaluated. In order to determine the functional muscular strength of the body and the lower extremities, the step number will be recorded by taking straight step to the stair test and taking side step to the stair test in 15 seconds. Change from baseline Functional muscular strength at 10 weeks
Secondary Isometric strength of bilateral lower extremity muscles and trunk muscles will be evaluated. For the evaluation of isometric strength of bilateral lower extremity muscles and body muscles, a hand held dynamometer will be used which is in standard positions and independent from the gravity and the obtained measurement will be recorded by adjusting it to the body weight. The strength obtained by isometric contraction and by equipment resistance applied on key chosen muscles, will be recorded as a numerical value. Change from baseline isometric strength at 10 weeks
Secondary Muscular tonus in lower extremities will be evaluated. The muscular tonus in lower extremities will be evaluated as bilateral by Modified Ashworth Scale (MAS). The joint will be moved passively, fast and reverse to the muscular functions that will be tested in this scale -which is used for the determination of spasticity severity. According to the resistivity occurred, scoring is done between 0-4 points. Change from baseline muscular tonus at 10 weeks
Secondary Walking speed and main mobility will be evaluated. For the determination of walking speed and main mobility; timed up and go (TUG) test will be used. 3 meter walking distance will be recorded. Change from baseline walking speed and main mobility at 10 weeks
Secondary Functional motor performance will be evaluated. For the determination of functional motor performance; sitting and getting up test of Motor Assessment Scale will be used. Without a back and arm support, the chair sitting and getting up number in 1 minute will be recorded. Change from baseline functional motor performance at 10 weeks
Secondary Satisfaction of children from the exercises will be evaluated. For the measurement of satisfaction of children from the exercises to be applied, Physical Activity Enjoyment Scale (PACES) will be used. The children will be asked to mark the numbers suitable for themselves after reading child items in the 5 likert point scale. The points taken on the scale, change between 5 and 25. At 10 weeks.
Secondary Activity and participation level will be evaluated. Canadian Occupational Performance Test (COPM) will be used in order to evaluate activity and participation level. COPM is an interview based method and the participant is asked to express the daily activities they needed, desired and they are not able to do. They are asked to express these activities under 3 headlines (self care activities, productivity and free time activities) and they are asked to determine these according to the priority for themselves. The first desire/problem is 10 points, and last is 1 point. Change from baseline COPM at 10 weeks
Secondary Quality of life will be evaluated. For the evaluation of life quality; Life Quality Scale for Children (LQSC) will be used (PedsQL) (5-7 age SP family reported model,5-7 age SP model, 8-12 age SP model, 13-18 age SP model). 23 questions will be used for the case which consists of 0-4 points and Working/Job Functions, Social, Physical and Emotional Functions in the last one month. The obtained point gives information about the life quality Change from baseline LQSC at 10 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Completed NCT00011024 - Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy Phase 2
Recruiting NCT05810779 - Dynamic Surface Exercise and Trunk Targeted Training in Children With Spastic Cerebral Palsy N/A
Completed NCT01049581 - Effects of Pediatric Aquatic Therapy in Children With Spastic Cerebral Palsy N/A
Completed NCT04634136 - Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy N/A
Recruiting NCT06070233 - Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy N/A
Completed NCT01815814 - Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy N/A
Recruiting NCT05113433 - Effects of Different Time Period of Standing Frame on Spasticity and Gait in Children With Spastic Cerebral Palsy. N/A
Recruiting NCT03676439 - Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy Phase 2/Phase 3
Completed NCT03708757 - Effect of Post Isometric Relaxation Technique & Eccentric Muscle Contraction on Hamstring Spasticity in CP N/A
Completed NCT04078321 - Evaluation of Multifocal Transcutaneous Electrical Stimulation for Self-treatment Among Children With Cerebral Palsy N/A
Active, not recruiting NCT06330311 - Effectiveness of Whole-Body Vibration N/A
Terminated NCT00955877 - Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children N/A
Completed NCT02359799 - Robotic Rehabilitation of Cerebral Palsy N/A
Not yet recruiting NCT05340439 - INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT) Phase 2
Completed NCT01147653 - A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy Phase 2
Recruiting NCT04925102 - Prediction of Recovery in Spastic Cerebral Palsy.
Completed NCT05094921 - Halliwick Concept on Motor Functions in Spastic CP N/A
Completed NCT04322825 - Mollii - Personalized Suit for Treatment of Spasticity, GFMCS 3-5 N/A
Recruiting NCT06044168 - Feasibility Nutritional Supplements for Muscle Growth in CP N/A